Cannabis Pharma cannabinoid compound shows encouraging action in preclinical study; shares up 7%

Cannabis Pharmaceuticals (OTCQB:CNBX +6.9%) says one of its cannabinoid compounds demonstrated a greater ability to kill cancer cells than traditional chemo in a preclinical study. No other information is provided.

...read more at https://seekingalpha.com/news/3390411-cannabis-pharma-cannabinoid-compound-shows-encouraging-action-preclinical-study-shares-7

by